Production (Stage)
Serina Therapeutics, Inc.
SER
$5.75
$0.01430.25%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 51.00K | 56.00K | 3.16M | 3.17M | 3.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.00K | 56.00K | 3.16M | 3.17M | 3.13M |
| Cost of Revenue | 9.33M | 7.48M | 6.02M | 4.21M | 3.10M |
| Gross Profit | -9.27M | -7.42M | -2.87M | -1.04M | 33.00K |
| SG&A Expenses | 9.84M | 8.15M | 6.79M | 4.77M | 2.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.16M | 15.63M | 12.82M | 8.98M | 6.02M |
| Operating Income | -19.11M | -15.57M | -9.66M | -5.81M | -2.89M |
| Income Before Tax | -1.01M | -11.21M | -7.40M | -7.04M | -11.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.01 | -11.21 | -7.40 | -7.04 | -11.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 75.00K | 66.00K | 54.00K | 27.00K | -- |
| Net Income | -939.00K | -11.14M | -7.35M | -7.01M | -11.40M |
| EBIT | -19.11M | -15.57M | -9.66M | -5.81M | -2.89M |
| EBITDA | -18.92M | -15.38M | -9.52M | -5.67M | -2.79M |
| EPS Basic | -0.31 | -5.20 | -4.18 | -3.53 | -3.77 |
| Normalized Basic EPS | 0.01 | -1.48 | -0.85 | -1.20 | -1.80 |
| EPS Diluted | -0.15 | -5.04 | -4.59 | -4.49 | -4.88 |
| Normalized Diluted EPS | -0.07 | -1.56 | -1.22 | -1.38 | -1.76 |
| Average Basic Shares Outstanding | 45.66M | 38.69M | 22.57M | 15.91M | 9.56M |
| Average Diluted Shares Outstanding | 49.20M | 42.23M | 30.46M | 27.29M | 24.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |